Massachusetts Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
VPM
VCM
Massachusetts Financial Services's IONS Position: Q1 2026 in Review
Massachusetts Financial Services reduced its Ionis Pharmaceuticals (IONS) stake by 18% in Q1 2026, selling an estimated $11.6M and leaving 666,116 shares worth $50M. The position accounts for 0.02% of the portfolio, ranked #477.
Massachusetts Financial Services first reported a position in IONS in Q1 2014 and has held it in 18 quarters since. The position peaked at $67.8M in Q4 2014. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Massachusetts Financial Services held 666,116 shares of Ionis Pharmaceuticals worth $50M as of Q1 2026.
- Massachusetts Financial Services sold 146,631 Ionis Pharmaceuticals shares in Q1 2026, an estimated $11.6M.
- Ionis Pharmaceuticals made up 0.02% of Massachusetts Financial Services's portfolio in Q1 2026, its #477 holding.
- Massachusetts Financial Services first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
- Massachusetts Financial Services's Ionis Pharmaceuticals position peaked at $67.8M in Q4 2014.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.